Skip to main content

Advertisement

Table 2 Performance Characteristics of MSIplus, Large-Panel NGS, and MSI-PCR in Prostate Cancer

From: Microsatellite instability in prostate cancer by PCR or next-generation sequencing

Assay Sensitivity [95% CI] Specificity [95% CI]
MSIplus 96.6% [80.4%–99.8%] 100% [92.7%–100%]
Large-Panel NGS 93.1% [75.8%–98.8%] 98.4% [90.2%–99.9%]
MSI-PCR 72.4% [52.5%–86.6%] 100% [92.7%–100%]